<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04260958</url>
  </required_header>
  <id_info>
    <org_study_id>U-2018-312</org_study_id>
    <nct_id>NCT04260958</nct_id>
  </id_info>
  <brief_title>Remote Exercise SWEDEHEART Study</brief_title>
  <official_title>Remote Exercise SWEDEHEART Study - a Multicentre Registry-based Cluster Randomized Crossover Clinical Trial (RRCT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates if remote video exercise-based cardiac rehabilitation (exCR), offered as
      an alternative to centre-based exCR, can increase the proportion of patients post myocardial
      infarction (MI) successfully completing an exCR-program.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary aim is to evaluate if remote video exCR, offered as an alternative to centre-based
      exCR, can increase the proportion of patients post myocardial infarction (MI) successfully
      completing an exCR-program.

      Secondary aims are to investigate if remote video exCR is at least as effective as
      centre-based exCR, in terms of physical fitness, patient-reported outcome measures (PROMs)
      and cost-effectiveness. Follow-up of cardiovascular events (all-cause mortality,
      cardiovascular mortality, recurrent hospitalization for acute coronary syndrome (ACS), heart
      failure and stroke, and repeat coronary revascularization) will be performed.

      CR centers (not patients) will be cluster randomized to either the intervention or control.
      Patients at intervention centers will be offered remote video exCR or usual care centre-based
      exCR, as self-preferred choice. At control centers, patients will be offered usual care
      centre-based exCR only. The duration of each time period for each center will be
      approximately 15 months.

      A number of 1500 of eligible patients post MI, meeting the inclusion and exclusion criteria
      over a period of approximately three years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 3, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>CR centers will be cluster randomized and start as either the intervention or control center. Patients at intervention centers will be offered remote video exCR (first-hand option) or usual care centre-based exCR. At control centers, patients will be offered usual care centre-based exCR only. The duration of each time period for each center will be 15 months and then cross-over will occur, so that intervention centers become control centers and the other way around. At intervention centers, patients participating in remote exCR will finish their 3-month exercise period, but no new patients will be offered remote exCR after the cross-over has occurred.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients post MI successfully completing an exCR program</measure>
    <time_frame>3 years</time_frame>
    <description>The primary outcome is proportion of patients post MI successfully completing an exCR-program. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Submaximal exercise capacity</measure>
    <time_frame>3-4 months</time_frame>
    <description>Bicycle ergometer test according to the WHO-protocol with an increased workload of 25W every 4.5 minutes. The exercise test is discontinued at Borg RPE 17 and/or dyspnea 7 at Borg´s CR-10 scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular endurance tests</measure>
    <time_frame>3-4 months</time_frame>
    <description>Unilateral isotonic shoulder flexion (maximum number of repetitions) and a unilateral isotonic heel lift (maximum number of repetitions)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical activity and exercise</measure>
    <time_frame>3-4 months</time_frame>
    <description>Two questions on physical activity and exercise during the latest week according to Haskell´s questionnaire (Min:0, Max:7). Ordinal scale, number of days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical activity and exercise</measure>
    <time_frame>3-4 months</time_frame>
    <description>Haskell´s questionnaire (Min:0, Max:7). A high score means higher level of physical activity and exercise.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical capacity</measure>
    <time_frame>3-4 months</time_frame>
    <description>Visual analog scale, (100=best possible physical capacity, 0=worst possible physical capacity), a dichotomous question: Do you experience any limitation in everyday life due to your current physical capacity? (yes vs no). If yes: multiple choice on reasons</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>3-4 months</time_frame>
    <description>Euro Quality of Life (EQ-5D 3L). The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. A high score indicates better Health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>3-4 months</time_frame>
    <description>Euro Quality of Life VAS. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale where the endpoints are labelled 'Best imaginable health state'(100) and 'Worst imaginable health state' (0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kinesiophobia (fear of movement)</measure>
    <time_frame>3-4 months</time_frame>
    <description>Tampa Scale for Kinesiophobia Heart (17 items, ordinal scale 1-4) 1, strongly disagree, 4, strongly agree. A higher score is means higher values of kinesiophobia (worse).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy for Exercise Scale</measure>
    <time_frame>3-4 months</time_frame>
    <description>Self-efficacy for Exercise Scale. 9 items, ordinal scale. 0=not Confident, 10=very Confident. Total score is calculated by summing the responses to each question. This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported perceptions on exercise</measure>
    <time_frame>3-4 months</time_frame>
    <description>Patient´s perceptions of remote exCR or centre-based exCR. 1, strongly disagree, 4, strongly agree. This questionnarie is designed by the authors. High score, better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>End of study</time_frame>
    <description>A cost-effectiveness analysis will be performed in order to estimate the cost per quality-adjusted life-year (QALY) associated with the intervention compared with control. Healthcare costs associated with investigated treatments will be assessed by extracting resource use from the relevant registries, and QALYs will be determined by combining survival status and the quality-of-life measurements provided by the EQ-5D-3L instrument.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Socio-economic evaluation</measure>
    <time_frame>6 years</time_frame>
    <description>Data from Statistics Sweden will be used to evaluate study results in relation to socio-economic data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Cardiovascular events</measure>
    <time_frame>1 and 3 years after the last patient visit</time_frame>
    <description>All-cause mortality, cardiovascular mortality, recurrent hospitalization for ACS, heart failure and stroke and repeat coronary revascularization, reported in SWEDEHEART, the National Patient Register and the Cause of Death Register will be performed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Intervention center</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients at intervention centers will be offered remote video exCR (first-hand option) or usual care centre-based exCR. The exercise program (remote/centre-based) will be standardized and performed for totally 60 minutes, 2 times a week for 3 months. Exercise will be individually prescribed and progressed by physiotherapists in accordance with guidelines. Patients will also be asked to perform one additional session of at least 30 min aerobic exercise per week, at intensity level 13-15 according to Borg RPE-scale.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>At control centers, patients will be offered usual care centre-based exCR only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise-based cardiac rehabilitation</intervention_name>
    <description>The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ≈ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending ≥75% of the 24 sessions over a 4-month period will be considered as successful.</description>
    <arm_group_label>Intervention center</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Diagnosis of acute myocardial infarction (AMI)

          -  Age 18-79 years at discharge from hospital

        Exclusion Criteria:

          -  Patients with incomplete coronary revascularization defined as at least one remaining
             hemodynamically significant stenosis

          -  Severe valve or structural heart disease

          -  Severe heart failure (NYHA IIIb - IV)

          -  Inability to understand Swedish

          -  No internet access at home (only applicable for intervention group)

          -  Any condition that may interfere with the possibility for the patient to comply with
             the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria Back, Ass Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska University Hospital, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan James, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Uppsala Clinial Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Back, Ass Prof</last_name>
    <phone>+46700895612</phone>
    <email>maria.m.back@vgregion.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisabeth Palmcrantz Graf</last_name>
    <phone>+46186119542</phone>
    <email>elisabeth.palmcrantz-graf@ucr.uu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Södra Älvsborg Hospital</name>
      <address>
        <city>Borås</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ellinor Nylund, RPT</last_name>
      <email>ellinor.nylund@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Ellinor Nylund, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eksjö Hospital</name>
      <address>
        <city>Eksjö</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julia Braf, RPT</last_name>
      <email>julia.braf@rjl.se</email>
    </contact>
    <investigator>
      <last_name>Julia Braf, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Falun hospital</name>
      <address>
        <city>Falun</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Björn von Hofsten, RPT</last_name>
      <email>bjorn.vonhofsten@regiondalarna.se</email>
    </contact>
    <investigator>
      <last_name>Björn von Hofsten, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanna Wittboldt, RPT</last_name>
      <email>susanna.wittboldt@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Maria Back, Ass Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexandra Larsson, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gävle hospital</name>
      <address>
        <city>Gävle</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna Janson, RPT</last_name>
      <email>anna.m.janson@regiongavleborg.se</email>
    </contact>
    <investigator>
      <last_name>Anna Janson, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Halmstad hospital</name>
      <address>
        <city>Halmstad</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jeanette Sehlberg, RPT</last_name>
      <email>jeanette.sehlberg@regionhalland.se</email>
    </contact>
    <investigator>
      <last_name>Jeanette Sehlberg, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hudiksvall hospital</name>
      <address>
        <city>Hudiksvall</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Moa Andersson, RPT</last_name>
      <email>moa.m.andersson@regiongavleborg.se</email>
    </contact>
    <investigator>
      <last_name>Moa Andersson, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jönköping Ryhov hospital</name>
      <address>
        <city>Jönköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elin Lundberg, RPT</last_name>
      <email>elin.lundberg@rjl.se</email>
    </contact>
    <investigator>
      <last_name>Elin Lundberg, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kalix hospital</name>
      <address>
        <city>Kalix</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eva Öberg, RPT</last_name>
      <email>eva.oberg@norrbotten.se</email>
    </contact>
    <investigator>
      <last_name>Eva Öberg, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lindesberg</name>
      <address>
        <city>Lindesberg</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcus Bargholtz, RPT</last_name>
      <email>marcus.bargholtz@regionorebrolan.se</email>
    </contact>
    <investigator>
      <last_name>Marcus Bargholtz, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sabina Borg, RPT</last_name>
      <email>sabina.borg@liu.se</email>
    </contact>
    <investigator>
      <last_name>Sabina Borg, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunderbyn hospital</name>
      <address>
        <city>Luleå</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elin Ståhlman, RPT</last_name>
      <email>elin.stahlman@norrbotten.se</email>
    </contact>
    <investigator>
      <last_name>Elin Ståhlman, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skåne University hospital</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Simon Holm, RPT</last_name>
      <email>simon.holm@skane.se</email>
    </contact>
    <investigator>
      <last_name>Simon Holm, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norrköping Vrinnevi hospital</name>
      <address>
        <city>Norrköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Warfman, RPT</last_name>
      <email>maria.warfman@regionostergotland.se</email>
    </contact>
    <investigator>
      <last_name>Maria Warfman, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oskarshamn hospital</name>
      <address>
        <city>Oskarshamn</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linnea Gerhardsson, RPT</last_name>
      <email>linnea.gerhardsson@regionkalmar.se</email>
    </contact>
    <investigator>
      <last_name>Linnea Gerhardsson, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skaraborg hospital</name>
      <address>
        <city>Skövde</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jenny Duvå, RPT</last_name>
      <email>jenny.duva@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Jenny Duvå, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sundsvall hospital</name>
      <address>
        <city>Sundsvall</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Annika Henriksson, RPT</last_name>
      <email>annika.henriksson@rvn.se</email>
    </contact>
    <investigator>
      <last_name>Annika Henriksson, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NU-sjukvården</name>
      <address>
        <city>Trollhättan</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kristina Åhlund, MSc</last_name>
      <email>kristina.ahlund@vgregion.se</email>
    </contact>
    <investigator>
      <last_name>Kristina Åhlund, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Värnamo hospital</name>
      <address>
        <city>Värnamo</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monia Lennnartsson, RPT</last_name>
      <email>monia.lennartsson@rjl.se</email>
    </contact>
    <investigator>
      <last_name>Monia Lennartsson, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Östersund hospital</name>
      <address>
        <city>Östersund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mattias Pettersson, RPT</last_name>
      <email>mattias.pettersson@regionjh.se</email>
    </contact>
    <investigator>
      <last_name>Mattias Pettersson, RPT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 4, 2020</study_first_submitted>
  <study_first_submitted_qc>February 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2020</study_first_posted>
  <last_update_submitted>February 5, 2020</last_update_submitted>
  <last_update_submitted_qc>February 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Maria Bäck</investigator_full_name>
    <investigator_title>Associate professor, physiotherapist</investigator_title>
  </responsible_party>
  <keyword>Exercise-based cardiac rehabilitation</keyword>
  <keyword>Secondary prevention</keyword>
  <keyword>EHealth</keyword>
  <keyword>Telerehabilitation</keyword>
  <keyword>Physical fitness</keyword>
  <keyword>Health-related quality of life</keyword>
  <keyword>cost-effectiveness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

